Species | Glucuronide | Site | Apparent Km (Ksi)a | Apparent Vmax | Apparent CLint |
---|---|---|---|---|---|
μM | pmol/min/mg | μl/min/mg | |||
Human | M1 | Liverb | 14.48 | 1183 | 82 |
Jejunumb | 4.89 | 348 | 71 | ||
Ileumb | 8.72 | 424 | 49 | ||
M2 | Liverb | 3.63 | 747 | 206 | |
Jejunumb | 3.68 | 3711 | 1008 | ||
Ileumb | 4.88 | 3871 | 793 | ||
Rat | M1 | Liverb | 3.04 | 603 | 199 |
Duodnumc | 2.42 (26.00)a | 750 | 309 | ||
Jejunumc | 1.40 (44.31)a | 419 | 300 | ||
Ileumc | 0.95 (47.80)a | 117 | 124 | ||
Colonc | 0.85 (74.27)a | 145 | 170 | ||
M2 | Liverb | 4.39 | 161 | 37 | |
Duodnumc | 13.98 (4.76)a | 678 | 49 | ||
Jejunumc | 11.93 (6.09)a | 368 | 31 | ||
Ileumc | 3.518 (23.83)a | 39 | 11 | ||
|
| Colonb | 0.77 | 23 | 30 |
↵ a The constant describing the substrate inhibition interaction (Ksi) was calculated according to eq. 3 as described under Materials and Methods
↵ b The parameters were calculated from the data up to 34.7 μM raloxifene using the Michaelis-Menten equation
↵ c The parameters were calculated according to eq. 3 as described under Materials and Methods since it showed substrate inhibition (see Results)